S&P Healthcare Services SPDR (XHS)

Henry Schein has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Universal Health Services has notably underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

McKesson has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

DaVita has outpaced the broader market over the past year, with Wall Street analysts maintaining a cautiously optimistic outlook on the stock’s long-term prospects.

Humana has scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a significant loss.

Elevance Health is scheduled to release its Q4 results next month, and analysts project a double-digit drop in profit.

Humana stock has underperformed compared to the healthcare services group, but analysts remain fairly bullish about its prospects.

After a year of clear underperformance, analysts are hitting pause and taking a more skeptical view of Molina Healthcare’s outlook.

Quest Diagnostics has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Although Cigna Group has lagged the broader market, analysts remain bullish about its prospects.